PROGRESSIVE FIBROSING INTERSTICIAL LUNG DISEASE OF AUTOIMMUNE ORIGIN AND ANTIFIBROTIC MEDICATION: SOCIODEMOGRAPHIC, CLINICAL AND THERAPEUTIC CHARACTERISTICS OF THE NEREA COHORT - Amsterdam 2025

Population-based studies in interstitial lung diseases

Chair(s): Antje Prasse, Juergen Behr

Session type: Poster session

PROGRESSIVE FIBROSING INTERSTICIAL LUNG DISEASE OF AUTOIMMUNE ORIGIN AND ANTIFIBROTIC MEDICATION: SOCIODEMOGRAPHIC, CLINICAL AND THERAPEUTIC CHARACTERISTICS OF THE NEREA COHORT

Cristina Matesanz Lopez

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Attitudes to symptom palliation and palliative care amongst people with interstitial lung disease and their carers

Natasha Smallwood

Poster

Abstract

PROGRESSIVE FIBROSING INTERSTICIAL LUNG DISEASE OF AUTOIMMUNE ORIGIN AND ANTIFIBROTIC MEDICATION: SOCIODEMOGRAPHIC, CLINICAL AND THERAPEUTIC CHARACTERISTICS OF THE NEREA COHORT

Cristina Matesanz Lopez

Poster

Abstract

Age-standardised Prevalence, Incidence and Mortality Rates of ILD in Saudi Arabia: A systematic analysis of ILD from 1990 to 2021

Malik A Althobiani

Poster

Abstract

Progressive fibrosing interstitial lung disease non-IPF followed in a pulmonology departement

Sara Talha

Poster

Abstract

Clinical score for probability of pulmonary hypertension in a cohort of interstitial lung diseases

Ana Karem Saucedo Pruneda

Poster

Abstract

Long-term outcomes of lung transplant patients due to interstitial lung diseases

Ana Belén Llanos Gonzalez

Poster

Abstract

All cause admissions in interstitial lung diseases: A retrospective cohort study

Gayathri Mohan

Poster

Abstract

Radiological evolution of severe SARS-CoV-2 Pneumonia: A 48-Month cohort study.

Ahmad Hamod Tammawi

Poster

Abstract

The challenge of defining progression: comparison of different criteria for classification of Progressive Pulmonary Fibrosis in a real-life setting

Giuseppe Muscato

Poster

Abstract

Prevalence and associated factors of lung progression in patients with rheumatoid arthritis and interstitial lung disease

Maria Otaola

Poster

Abstract

Thoracic ultrasound in patients with fibrosing interstitial lung diseases: a systematic review.

Sanjeewa Patabendige

Poster

Abstract

Automated AI detection of interstitial lung disease on CT in the COPDGene trial: sub-analysis of COPD vs. non-COPD patients

Sahithee Batchu

Poster

Abstract

Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD): A novel biomarker?

Niels Schröder

Poster

Abstract

The Association Between Anti-MDA5 antibody and Clinical manifestations in DM or PM Patients with ILD: A Systematic Review and Meta-analysis

Yidan Sun

Poster

Abstract

Pulmonary hypertension in patients with moderate to severe hypersensitivity pneumonitis

Tjasa Kamenski

Poster

Abstract

Trends in the demographic profile of Interstitial Lung Disease at a tertiary care center in India: A decadal analysis

Sheetu Singh

Poster

Abstract

The mortality burden of hypersensitivity pneumonitis across Europe

Ella Girdler

Abstract

The increasing secondary burden from Hypersensitivity Pneumonitis in England

Ella Girdler

Abstract

Clinical and functional characteristics of our pneumoconiosis cases

Pinar Yildiz Gülhan

Poster

Abstract

A RETROSPECTIVE, OBSERVATIONAL STUDY OF SPANISH HYPERSENSITIVITY PNEUMONITIS COHORT

Laura Rossi

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}